Sensex, Nifty start on a positive note; bank stocks jump
.jpg)
Benchmark indices started on a positive note on February 21 tracking gains on banking counters, after the government announced infusion ₹48,239 crore in 12 public sector banks, buying by foreign and domestic institutional investors, and positive global cues.
The 30-share index was trading 8.47 points, or 0.02%, at 35,764.73. Similarly, the 50-share NSE Nifty was trading 6.05 points, or 0.06%, higher at 10,741.50.
The Sensex had settled at 35,756.26, up 403.65 points, or 1.14% in the previous session, while the broader NSE Nifty soared 131.10 points, or 1.24%, to 10,735.45.
Top gainers in the Sensex pack on Thursday include ICICI Bank, Vedanta, ONGC, SBI, HUL, Bajaj Finance, Tata Motors, Sun Pharma, HUL and Axis Bank, rising up to 2.23%.
On the other hand, Infosys, Yes Bank, Bharti Airtel, M&M, Coal India and HDFC Bank fell up to 1.28%.
According to traders, public sector bank stocks rose after the finance ministry on Wednesday announced infusion of ₹48,239 crore in 12 public sector banks (PSBs) in this fiscal to help them maintain regulatory capital requirements and finance growth plans.
Besides, investor sentiment was also positive on buying by domestic institutional investors (DIIs) and foreign institutional investors (FIIs).
On a net basis, DIIs were net buyers to the tune of ₹113.27 crore, and FIIs also bought shares worth a net of ₹713.47 crore on Wednesday, provisional data available with BSE showed.
Investors also took cues from other Asian equities that were trading positive after the US Federal Reserve minutes affirmed that the central bank would be patient on interest rate hikes, amid anticipation of a resolution to US-China trade tiff.
Hong Kong’s Hang Seng was up 0.54%, Kospi rose 0.05%, and Japan’s Nikkei gained 0.35%; while Shanghai Composite Index was trading 0.36% in early trade.
On Wall Street, Dow Jones Industrial Average ended 0.24% higher at 25,954.44 points on Wednesday.
The benchmark Brent crude futures rose 0.21% to $67.22 per barrel.
Meanwhile, the rupee appreciated to 71.02 against the US dollar in early session.
Other Latest News
.webp)
Samajwadi Party MP Dimple Yadav has said India will go back 15 years if the BJP wins the Lok Sabha polls, accusing the party of practising "divisive politics" to divert attention from real issues.
In an exclusive interview with PTI, Dimple Yadav, who is aiming to carry forward the legacy of her father-in-law and SP patriarch late Mulayam Singh Yadav by retaining the Mainpuri seat, asserted that the people are going to vote for change this time.
.webp)
Microsoft will invest $1.7 billion over the next four years into expanding cloud services and artificial intelligence in Indonesia, including building data centres, visiting chief executive Satya Nadella said on Tuesday.
Jakarta is Nadella's first stop on a trip to Southeast Asian countries aimed at promoting the US company's generative AI technology. He will go to Malaysia and Thailand later this week.
.webp)
JNK India stock made a strong market debut on Tuesday with its shares getting listed at Rs 621, a 50 per cent premium over its issue price of Rs 415 per share on the National Stock Exchange (NSE). Post listing, the stock moved to an intraday high of Rs 665, 60 per cent up over issue price.
At 10:02 am, JNK India stock was trading at Rs 651, 57 per cent higher than issue price, with around 6.19 million equity shares changing hands on the NSE, data shows.
.webp)
HSBC said on Tuesday its Chief Executive Noel Quinn will retire - a surprise departure by its hard-nosed leader of five years who has overseen a sweeping series of asset sales across the globe.
The bank said it has launched a formal process to find a successor.
.webp)
AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. According to media reports, the admission was made in a legal document submitted to the UK High Court in February.
The company stated in the document that a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS) can happen even if there is no vaccination.
.webp)
.webp)
.webp)
.webp)
.webp)
